Nicole Gifford
Amgen’s Amgevita Receives Approval in Europe
Biosimilars Law Bulletin ·
Celltrion Targets Four More Herceptin® Patents in IPR Petitions
Biosimilars Law Bulletin ·
Sanofi and Regeneron Seek Declaratory Judgment that Dupixent® (Dupilumab) Does Not Infringe Amgen’s Patent
Biosimilars Law Bulletin ·
PTAB Institutes First IPR on Bevacizumab Patent
Biosimilars Law Bulletin ·
Celltrion Files Three IPR Petitions on Rituximab Patents
Biosimilars Law Bulletin ·